New Jersey needs a new strategic plan to end its opioid crisis
The opioid epidemic has ravaged communities across New Jersey, leaving a wake of immeasurable suffering that transcends age, gender and socioeconomic status. As New Jersey is set to receive a significant amount of money from the national opioid settlement, the need to respond with a comprehensive and all-encompassing approach has never been greater. Our mission is clear: to alleviate the suffering of those affected, support individuals grappling with opioid use disorder and reinforce programs that prevent future dependencies and addiction.
At the forefront of our priorities must be the establishment of a robust network of care and prevention. Connecting individuals to appropriate care, reducing overprescribing of opioids and supporting at-risk populations are paramount.
A substantial portion of the settlement funds should be earmarked for addiction treatment, mental health services, and counseling, underscoring our commitment to individuals and families forever impacted by opioid misuse. This support is crucial and can help them rebuild their lives.
We must also place prevention programs at the core of our efforts. By equipping communities with the necessary tools and knowledge to ward off opioid misuse, we take a significant step toward prevention. This calls for targeted prevention initiatives in schools, community centers, and healthcare settings.
New Jersey is a frontrunner in adopting innovative approaches to address the root causes of addiction. The Partnership for a Drug-Free New Jersey has been at the helm of this battle against opioids, blazing trails even before the crisis gained national attention. We developed the first-ever American Medicine Chest Challenge in the United States, which included steps people can take to protect their families from addiction. This was used as the inspiration and model for the DEA National Prescription Drug Take-Back Day.
New Jersey has also set a precedent in informed decision-making regarding opioids. The Opioid Patients' Right to Know Act, championed by PDFNJ, mandates meaningful conversations between healthcare providers and patients about the addictive nature of opioids and alternative pain management options. We became the first state to enact this law, inspiring 19 others to follow suit. Our vision is to see this legislation adopted nationwide, ensuring that individuals are well-informed of the potential risks associated with opioid prescriptions and are empowered to make choices that protect their health.
The opioid settlement funds present a unique and pivotal opportunity to confront the opioid epidemic head-on, supporting those harmed and building a healthier New Jersey. PDFNJ remains unwavering in its dedication to ensuring that 100% of these funds are used to save lives, prevent misuse, and pave the way for a future free from opioid use disorder.
Angelo M. Valente is executive director of the Partnership for a Drug-Free New Jersey
This article originally appeared on Asbury Park Press: New Jersey opioid crisis: Opioid settlement money presents opportunity
